Enhanced haemodynamic effects of propranolol in acute myocardial infarction. 1984

B Silke, and G I Nelson, and S P Verma, and M Hussain, and R C Ahuja, and C Walker, and S H Taylor

To evaluate the possible influence of sympathetic activation on the haemodynamic response to intravenous beta-blockade, the dose-response characteristics of three boluses of propranolol were evaluated in 8 patients with uncomplicated infarction and compared in a similar number of patients with stable angina. Following a control period, when haemodynamic stability was confirmed, propranolol 2, 2 and 4 mg (cumulative dosage 2, 4 and 8 mg) was injected into the central circulation at 15 min intervals. Despite close matching in baseline control haemodynamic variables between the groups, in stable angina, propranolol resulted in dose-related depression of cardiac output without change in systemic blood pressure, whereas following myocardial infarction the drug induced significantly greater falls in cardiac output (P less than 0.05) and a dose-related decrease in systemic blood pressure. Despite the greater effects of propranolol on cardiac output following myocardial infarction, the left ventricular filling pressure was increased to a lesser extent compared with stable angina. The explanation for this observation may reside in a greater susceptibility of the left ventricular wall to increase its compliance, under conditions of high sympathetic stimulation, following beta-blockade. These data support experimental and biochemical evidence of sympathetic activation in myocardial infarction; the hyperadrenergic state conditions an augmented haemodynamic response to competitive antagonism of sympathetic stimulation at cardiac beta-adrenoceptors.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002302 Cardiac Output The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat). Cardiac Outputs,Output, Cardiac,Outputs, Cardiac
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

B Silke, and G I Nelson, and S P Verma, and M Hussain, and R C Ahuja, and C Walker, and S H Taylor
January 1970, Thorax,
B Silke, and G I Nelson, and S P Verma, and M Hussain, and R C Ahuja, and C Walker, and S H Taylor
January 1967, British medical journal,
B Silke, and G I Nelson, and S P Verma, and M Hussain, and R C Ahuja, and C Walker, and S H Taylor
March 1968, The Medical journal of Australia,
B Silke, and G I Nelson, and S P Verma, and M Hussain, and R C Ahuja, and C Walker, and S H Taylor
July 1966, Acta medica Scandinavica,
B Silke, and G I Nelson, and S P Verma, and M Hussain, and R C Ahuja, and C Walker, and S H Taylor
May 1968, British medical journal,
B Silke, and G I Nelson, and S P Verma, and M Hussain, and R C Ahuja, and C Walker, and S H Taylor
January 1984, Postgraduate medical journal,
B Silke, and G I Nelson, and S P Verma, and M Hussain, and R C Ahuja, and C Walker, and S H Taylor
July 1972, British heart journal,
B Silke, and G I Nelson, and S P Verma, and M Hussain, and R C Ahuja, and C Walker, and S H Taylor
August 1971, Annals of clinical research,
B Silke, and G I Nelson, and S P Verma, and M Hussain, and R C Ahuja, and C Walker, and S H Taylor
November 1986, European heart journal,
B Silke, and G I Nelson, and S P Verma, and M Hussain, and R C Ahuja, and C Walker, and S H Taylor
March 1979, The Medical journal of Australia,
Copied contents to your clipboard!